Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.50 |
| ▸ | LMNA | P02545 | 2/20 | 0.50 |
| ▸ | CCR1 | P32246 | 2/20 | 0.50 |
| ▸ | CCR5 | P51681 | 2/20 | 0.50 |
| ▸ | CCR8 | P51685 | 2/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.50 |
| ▸ | POLB | P06746 | 1/20 | 0.50 |
| ▸ | METAP1 | P53582 | 1/20 | 0.50 |
| ▸ | BLM | P54132 | 1/20 | 0.50 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.50 |
| ▸ | DOHH | Q9BU89 | 1/20 | 0.50 |
| ▸ | P4HTM | Q9NXG6 | 1/20 | 0.50 |
| ▸ | GRM5 | P41594 | 1/20 | 0.50 |
| ▸ | NOS3 | P29474 | 2/20 | 0.46 |
| ▸ | NOS1 | P29475 | 2/20 | 0.46 |
| ▸ | NOS2 | P35228 | 2/20 | 0.46 |
| ▸ | NPC1 | O15118 | 2/20 | 0.46 |
| ▸ | HSP90AA1 | P07900 | 2/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2684 | 1.00 | — | — | |
| SCHEMBL29472848 | 1.00 | — | — | |
| SCHEMBL16322907 | 1.00 | KDM4E (0.50) | KDM4ELMNACCR1CCR5CCR8 | |
| SCHEMBL29599136 | 1.00 | KDM4E (0.50) | KDM4ELMNACCR1CCR5CCR8 | |
| SCHEMBL25382981 | 0.97 | — | — | |
| SCHEMBL21274595 | 0.97 | — | — | |
| SCHEMBL21528266 | 0.97 | — | — | |
| Hydrochloric Acid SCHEMBL21723652 | 0.97 | — | — | |
| Ethane SCHEMBL6683700 | 0.97 | — | — | |
| Hydrochloric Acid SCHEMBL2333819 | 0.97 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112500411-B | Preparation method of 1,1 '-ethylene-2, 2' -bipyridyl dichloride salt | 南京红太阳生物化学有限责任公司 | 2023-03-14 | — | — | CN | claimed |
| CN-115613061-A | Modification method of tryptophan and indole derivatives under electrooxidation condition | 浙江工业大学 | 2023-01-17 | — | — | CN | claimed |
| CN-115141138-B | Method for constructing fluoride by decarboxylation of alkyl carboxylic acid | 中山大学 | 2023-11-28 | — | — | CN | disclosed |
| WO-2023213271-A1 | HETEROCYCLIC COMPOUNDS, COMPOSITIONS THEREOF, AND METHODS OF TREATMENT THEREWITH | BEIGENE , LTD. (KY) | 2023-11-09 | — | — | WO | disclosed |
| CN-116940578-A | 5- [5- (piperidin-4-yl) thieno [3,2-C ] pyrazol-2-yl ] indazole derivatives and related compounds as modulators for splicing nucleic acids and for the treatment of proliferative diseases | 雷密克斯医疗公司 | 2023-10-24 | — | — | CN | disclosed |
| CN-116396159-A | Synthesis method of 2,2' -biphenyl dicarboxylic acid compound | 湖南大学 | 2023-07-07 | — | — | CN | disclosed |
| CN-115613061-A | Modification method of tryptophan and indole derivatives under electrooxidation condition | 浙江工业大学 | 2023-01-17 | — | — | CN | disclosed |
| US-20230002383-A1 | NOVEL FUNCTIONALIZED LACTAMS AS MODULATORS OF THE 5-HYDROXYTRYPTAMINE RECEPTOR 7 AND THEIR METHOD OF USE | PRAEVENTIX, LLC | 2023-01-05 | — | — | US | disclosed |
| CN-115141138-A | Method for constructing fluoride by decarboxylation of alkyl carboxylic acid | 中山大学 | 2022-10-04 | — | — | CN | disclosed |
| EP-4058455-A1 | NOVEL FUNCTIONALIZED LACTAMS AS MODULATORS OF THE 5-HYDROXYTRYPTAMINE RECEPTOR 7 AND THEIR METHOD OF USE | Temple University - Of The Commonwealth System of Higher Education (US) | 2022-09-21 | — | — | EP | disclosed |
| US-11059854-B2 | Method for preparing steroid derivative FXR agonist | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD. (CN) | 2021-07-13 | — | — | US | disclosed |
| WO-2008048216-A2 | ELECTROCATALYTIC DETECTION OF CARBON NANOTUBES | THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) | 2008-04-24 | — | — | WO | disclosed |
| EP-1259473-B1 | METHOD FOR PRODUCING CHLOROCARBOXYLIC ACID CHLORIDES | BASF AG (DE) | 2005-10-26 | — | — | EP | disclosed |
| US-6579959-B2 | Process for producing isobutylene polymers | KANEKA CORPORATION (JP) | 2003-06-17 | — | — | US | disclosed |
| US-20020193549-A1 | Process for producing isobutylene polymers | KANEKA CORPORATION | 2002-12-19 | — | — | US | disclosed |
| EP-1259473-A1 | METHOD FOR PRODUCING CHLOROCARBOXYLIC ACID CHLORIDES | BASF AKTIENGESELLSCHAFT (DE) | 2002-11-27 | — | — | EP | disclosed |
| US-20020037530-A1 | Detection of binding reactions using labels detected by mediated catalytic electrochemistry | STEWART DAVID H (US) | 2002-03-28 | — | — | US | disclosed |
| WO-2001064614-A1 | METHOD FOR PRODUCING CHLOROCARBOXYLIC ACID CHLORIDES | BASF AKTIENGESELLSCHAFT (DE) | 2001-09-07 | — | — | WO | disclosed |
| JP-2000169421-A | PRODUCTION OF ADIPOALDEHYDE ACID | MITSUBISHI CHEMICALS CORP | 2000-06-20 | — | — | JP | disclosed |
| WO-1997001559-A1 | ZINC(II) COMPLEXES AND METHODS RELATED THERETO | PROCYTE CORPORATION (US) | 1997-01-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11059854-B2 | Method for preparing steroid derivative FXR agonist | FXR1, NR1H4, FXR2 | KDM4E 4039/4885LMNA 3557/4885CCR1 1008/4885 |
| US-20230002383-A1 | NOVEL FUNCTIONALIZED LACTAMS AS MODULATORS OF THE 5-HYDROXYTRYPTAMINE RECEPTOR 7 AND THEIR METHOD OF USE | HTR7, HTR1A, HTR2C | KDM4E 4171/4885LMNA 4612/4885CCR1 1373/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.